Mounjaro®
Starting from £179.99/mo
Start journey Learn moreHair thinning on Wegovy is a recognised side effect, and it tends to show up two to four months after starting treatment. It is caused by the physical stress of rapid weight loss on your hair follicles, not by semaglutide itself damaging your hair. For most people, shedding slows and then stops without any intervention. The NHS semaglutide medicines page lists hair loss among the uncommon side effects reported during clinical use, and the condition has a name — telogen effluvium — that clinicians recognise well outside the context of weight-loss medicines.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most people who experience this notice it the same way: a little more on the pillow, more coming away in the shower. It rarely looks like the dramatic thinning of alopecia, but it is real, and the timing is the tell. Hair on your head grows in cycles. The "resting" phase is called telogen. Under physical stress (including the stress that comes from losing weight quickly) a larger proportion of follicles shift into that resting phase simultaneously. Around ten to twelve weeks later, when the resting hair finally sheds, you notice what looks like sudden hair loss.
The stress in question is not emotional. It is metabolic: a significant calorie deficit changes the resources available to non-essential biological processes, and hair growth is classified as non-essential. Rapid weight loss is one of the most consistent triggers of telogen effluvium in medical literature, and it pre-dates GLP-1 medicines by decades. Bariatric surgery patients, people who recover from serious illness, and women in the months after childbirth all describe the same pattern.
So when people ask whether Wegovy causes hair thinning, the honest answer is: Wegovy causes weight loss, and weight loss can cause temporary hair shedding. The distinction matters, because it changes how you think about it. There is no mechanism by which semaglutide damages the follicle itself, the NHS medicines guidance on semaglutide describes hair loss as uncommon rather than a primary or dose-dependent drug effect.
When your body is in a meaningful calorie deficit, it prioritises. The brain, heart and immune system take precedence. Hair follicles, which are metabolically hungry structures, get what is left over. Two nutritional factors come up consistently in clinical discussions about telogen effluvium: total protein intake and iron status.
Wegovy reduces appetite substantially, which is the point. But a reduced appetite can also mean less protein, less iron from meat and fish, and fewer of the B vitamins that support cell turnover. People who are hitting, say, 900 calories a day but spreading those calories across biscuits and toast are at much higher risk of shedding than those who are eating 1,200 to 1,500 calories with adequate protein distributed through meals. Dietitians typically suggest aiming for at least 1.2g of protein per kilogram of bodyweight while losing weight, though your prescriber or a registered dietitian is the right person to set a target for you personally.
It is also worth knowing that a multivitamin providing basic micronutrients is not a cure, but covering the bases makes nutritional-deficit hair loss less likely. If shedding is significant, a blood test to check ferritin, thyroid function and B12 is a reasonable step, something a GP can arrange. There is more about how semaglutide works on the semaglutide overview page if you want the mechanism in fuller detail.
In the majority of cases, shedding from telogen effluvium peaks around three to four months after it begins and then gradually reduces as the follicles cycle back into the growth phase. By six months, most people find it has resolved noticeably. Hair growth itself is slow, around 1.5cm a month, so regrowth takes time to become visible, but the shedding stops first.
Some things are worth flagging to your prescriber rather than waiting out. If thinning is happening in patches rather than diffusely across the scalp, that suggests a different cause. If it started very early in treatment, before significant weight loss could have occurred, that is also worth discussing. And if it is persisting beyond six to eight months without improvement, other causes (thyroid dysfunction, anaemia, autoimmune conditions) should be ruled out rather than assumed to be treatment-related.
People who are transferring to Wegovy from another treatment, or thinking about whether the hair impact differs across GLP-1 medicines, may find it useful to read about hair changes associated with Wegovy more broadly. For a closer look at whether the relationship is causal or correlational, the does Wegovy thin your hair page goes into more clinical depth.
If you are thinking about starting treatment and want to understand the full picture before you do, that is exactly the kind of question our prescribers expect at consultation. Wegovy is a prescription-only medicine sold under a brand name that the medicine is also known by; a clinician needs to assess your suitability, and that conversation is the right place to raise hair health alongside everything else. You can see an overview of what private treatment involves on the Wegovy page, or look at how Wegovy treatment is priced in the UK private market. A good consultation is free, and the prescriber reviewing your answers will be a GPhC-registered Independent Prescriber, not a queue in a piece of software. If you are ready to take that step, start your free consultation today.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.